Washington , DC
Columns
| Title | Category | Published |
|---|---|---|
| ‘The award for most memorable drug approval goes to…’ | Jul. 26, 2021 | |
| FDA proposes rule clarifying evidence for determining product’s intended use | Administrative/Regulatory | Nov. 2, 2020 |
| EO to ensure drug rebates are passed down to patients | Health Care & Hospital Law, Administrative/Regulatory | Sep. 15, 2020 |
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
| Bill would bring drugs that treat serious conditions to market faster | Health Care & Hospital Law | Jun. 16, 2020 |
| FDA, FTC issue joint statement on efforts to support market for biologics | Health Care & Hospital Law, Administrative/Regulatory | Feb. 24, 2020 |
| For hemp, skipping proposed rule stage could create problems | Administrative/Regulatory | May 16, 2019 |
Verdicts & Settlements
| Case Name | Topic | Role | Published |
|---|---|---|---|
| Consumer Advocacy Group Inc. v. Dollar Kings Inc., Dime Enterprises Inc., Dollar King Los Feliz, Kooba LLC, and Does 1-100 | Consumer Law | Defendant | Aug. 27, 2021 |
| Environmental Research Center Inc. v. N.V. Perricone LLC, and Does 1-100 | Consumer Law | Defendant | Dec. 6, 2019 |
| In the Matter of L'Occitane Inc. | Consumer Law | Defendant | Jan. 25, 2014 |
MCLE
| Title | Category | Published |
|---|---|---|
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
| Title | Category | Published |
|---|---|---|
| ‘The award for most memorable drug approval goes to…’ | Jul. 26, 2021 | |
| FDA proposes rule clarifying evidence for determining product’s intended use | Administrative/Regulatory | Nov. 2, 2020 |
| EO to ensure drug rebates are passed down to patients | Health Care & Hospital Law, Administrative/Regulatory | Sep. 15, 2020 |
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
| Bill would bring drugs that treat serious conditions to market faster | Health Care & Hospital Law | Jun. 16, 2020 |
| FDA, FTC issue joint statement on efforts to support market for biologics | Health Care & Hospital Law, Administrative/Regulatory | Feb. 24, 2020 |
| For hemp, skipping proposed rule stage could create problems | Administrative/Regulatory | May 16, 2019 |
| Case Name | Topic | Role | Published |
|---|---|---|---|
| Consumer Advocacy Group Inc. v. Dollar Kings Inc., Dime Enterprises Inc., Dollar King Los Feliz, Kooba LLC, and Does 1-100 | Consumer Law | Defendant | Aug. 27, 2021 |
| Environmental Research Center Inc. v. N.V. Perricone LLC, and Does 1-100 | Consumer Law | Defendant | Dec. 6, 2019 |
| In the Matter of L'Occitane Inc. | Consumer Law | Defendant | Jan. 25, 2014 |
| Title | Category | Published |
|---|---|---|
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
